Pubblicazioni

Bevacizumab-induced hypertension as a predictor of clinical outcome in metastatic colorectal cancer: An individual patient data-based pooled analysis of two randomized studies and a systematic review of the literature

2022 - CANCER TREATMENT REVIEWS

Lombardi, P.; Rossini, D.; Crespi, V.; Germani, M. M.; Bergamo, F.; Pietrantonio, F.; Santini, D.; Allegrini, G.; Daniel, F.; Pagani, F.; Antoniotti, C.; Zaniboni, A.; Conca, V.; Latiano, T. P.; Boccaccino, A.; Passardi, A.; Tamburini, E.; Masi, G.; Di Maio, M.; Cremolini, C.

New first-line immunotherapy-based combinations for metastatic renal cell carcinoma: A systematic review and network meta-analysis

2022 - CANCER TREATMENT REVIEWS

Lombardi, Pasquale; Filetti, Marco; Falcone, Rosa; Di Bidino, Rossella; Iacovelli, Roberto; Ciccarese, Chiara; Bria, Emilio; Tortora, Giampaolo; Scambia, Giovanni; Daniele, Gennaro

Survival and toxicity in neoadjuvant chemotherapy plus surgery versus definitive chemoradiotherapy for cervical cancer: a systematic review and meta-analysis

2020 - CANCER TREATMENT REVIEWS

Marchetti, C.; Fagotti, A.; Tombolini, V.; Scambia, G.; De Felice, F.

Rucaparib. An emerging parp inhibitor for treatment of recurrent ovarian cancer

2018 - CANCER TREATMENT REVIEWS

Musella, Angela; Bardhi, Erlisa; Marchetti, Claudia; Vertechy, Laura; Santangelo, Giusi; Sassu, Carolina; Tomao, Federica; Rech, Francesco; D'Amelio, Renzo; Monti, Marco; Palaia, Innocenza; Muzii, Ludovico; Benedetti Panici, Pierluigi